News & Updates
Filter by Specialty:

Letrozole-abemaciclib plus metformin shows promise in endometrial cancer treatment
05 May 2025
byStephen Padilla
Adding metformin to letrozole and abemaciclib does not cause serious safety concerns and may even encourage favourable responses among patients with oestrogen receptor (ER)-positive recurrent endometrial cancer (EC), according to a phase II study presented at SGO 2025.